Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 2 |
2021 | 1 |
2023 | 1 |
2024 | 3 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5.
Lancet Oncol. 2021.
PMID: 33684370
Clinical Trial.
[Oropharyngeal cancer].
Lafond C, Pointreau Y, Debelleix C, Denis F, Calais G, Bourhis J, Thariat J.
Lafond C, et al. Among authors: debelleix c.
Cancer Radiother. 2010 Nov;14 Suppl 1:S34-42. doi: 10.1016/S1278-3218(10)70006-8.
Cancer Radiother. 2010.
PMID: 21129668
French.
Item in Clipboard
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial.
Tougeron D, Dahan L, Evesque L, Le Malicot K, El Hajbi F, Aparicio T, Bouché O, Bonichon Lamichhane N, Chibaudel B, Angelergues A, Bodere A, Phelip JM, Mabro M, Kaluzinski L, Petorin C, Breysacher G, Rinaldi Y, Zaanan A, Smith D, Gouttebel MC, Perret C, Etchepare N, Emile JF, Sanfourche I, Di Fiore F, Lepage C, Artru P, Louvet C; PRODIGE 59-FFCD 1707-DURIGAST Investigators/Collaborators.
Tougeron D, et al.
JAMA Oncol. 2024 Apr 4. doi: 10.1001/jamaoncol.2024.0207. Online ahead of print.
JAMA Oncol. 2024.
PMID: 38573643
Item in Clipboard
Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLib.
Chamois J, Septans AL, Schipman B, Gross E, Blanchard N, Passerat V, Debelleix C, Hemery CG, Latorzeff I, Pointreau Y.
Chamois J, et al. Among authors: debelleix c.
Clin Transl Radiat Oncol. 2024 Mar 17;46:100762. doi: 10.1016/j.ctro.2024.100762. eCollection 2024 May.
Clin Transl Radiat Oncol. 2024.
PMID: 38572302
Free PMC article.
Item in Clipboard
Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis.
Yuste C, Passerat V, Calais G, Schipman B, Vaugier L, Paumier A, Huertas A, Hemery CG, Debelleix C, Chamois J, Blanchard N, Septans AL, Pointreau Y.
Yuste C, et al. Among authors: debelleix c.
Clin Transl Radiat Oncol. 2023 Dec 7;45:100708. doi: 10.1016/j.ctro.2023.100708. eCollection 2024 Mar.
Clin Transl Radiat Oncol. 2023.
PMID: 38162282
Free PMC article.
Item in Clipboard
[Normal tissue tolerance to external beam radiation therapy: larynx and pharynx].
Debelleix C, Pointreau Y, Lafond C, Denis F, Calais G, Bourhis JH.
Debelleix C, et al.
Cancer Radiother. 2010 Jul;14(4-5):301-6. doi: 10.1016/j.canrad.2010.05.002. Epub 2010 Jul 2.
Cancer Radiother. 2010.
PMID: 20598610
French.
Item in Clipboard
Cite
Cite